JENNIFER BYHAM: Open Payments
NPI 1720838444 · HUNTSVILLE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,610 in 72 payments from 24 companies in 2025. Trend: 2023 $0 · 2024 $520 · 2025 $1,610
Food & beverage: $1,610
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 13 | $286 |
| Novartis Pharmaceuticals Corporation | 9 | $214 |
| E.R. Squibb & Sons, L.L.C. | 7 | $126 |
| Baxter Healthcare | 1 | $116 |
| Daiichi Sankyo Inc. | 5 | $112 |
| Incyte Corporation | 4 | $83 |
| Blueprint Medicines Corporation | 3 | $77 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $70 |
| BeOne Medicines USA, Inc. | 3 | $52 |
| Celgene Corporation | 2 | $50 |
Products named: IMFINZI, Enhertu, PERCLOT, OPDIVO, Fabhalta, JAKAFI, AYVAKIT, REBLOZYL.
Industry payments across AL — which companies pay providers there.
